FDA Issues Notice to Rescind Laboratory Developed Test Rule
The agency signals intent to withdraw final rule extending regulatory authority to LDTs following federal court ruling that vacated the regulation.
Read MorePosted by CLP Edit Staff | Aug 26, 2025 | Compliance |
The agency signals intent to withdraw final rule extending regulatory authority to LDTs following federal court ruling that vacated the regulation.
Read MorePosted by CLP Edit Staff | Aug 25, 2025 | Accreditation |
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read MorePosted by CLP Edit Staff | Aug 25, 2025 | Compliance |
The new document provides framework for drug developers on appropriate use and modification of reference AST methods during antimicrobial development.
Read MorePosted by CLP Edit Staff | Aug 22, 2025 | Quality Control Programs |
Cloud-based quality control data management platform aims to reduce costly reruns and streamline QC reporting workflows.
Read MorePosted by CLP Edit Staff | Aug 21, 2025 | Information Technology |
The cloud-based EHR platform now offers real-time lab ordering and results delivery, eliminating the need for separate portals or fax-based communication.
Read More